Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03261856 · ClinicalTrials.gov registry record
Clinical Utility of Breath Tests in GI
A clinical trial, sponsored by Augusta University.
- Completed
- Registry status
- 1,080
- Enrollment target
NCT03261856 is a clinical trial that has completed, run by Augusta University. The registered enrollment target is 1,080 participants.
The verdict
NCT03261856 has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- 1,080 participants
- Enrollment target
Study Summary
Bloating, gas, pain and diarrhea are common complaints. Routine investigations are negative; these patients are labeled as IBS. In these patients, whether testing for carbohydrate malabsorption or small intestinal bacterial overgrowth (SIBO) is useful is unclear. Investigators aim to assess the prevalence of SIBO, fructose and lactose intolerance, the usefulness of breath tests, and predictive value of pre-test symptoms.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,080 participants |
| Start Date | 2011-08-31 |
| Est. Completion | 2017-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03261856
The ClinicalTrials.gov registry entry for NCT03261856 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,080 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03261856 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03261856 about?
NCT03261856 is a clinical study titled "Clinical Utility of Breath Tests in GI". Bloating, gas, pain and diarrhea are common complaints. Routine investigations are negative; these patients are labeled as IBS. In these patients, whether testing for carbohydrate malabsorption or small intestinal bacterial overgrowth (SIBO) is useful is unclear. Investigators aim to assess the prev...
What is the current status of trial NCT03261856?
This trial is currently completed. The enrollment target is 1,080 participants. The study started on 2011-08-31. Estimated completion is 2017-12-31.
Who is sponsoring clinical trial NCT03261856?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.